“Ask AI” delivers direct, cited answers to clinical questions grounded exclusively in ClinicalKey’s evidence-based content, including books, journals, and clinical guidelines.
NEW YORK, Aug. 27, 2026 /PRNewswire/ — Elsevier today announced the launch of “Ask AI,” a new generative AI feature integrated within ClinicalKey, its flagship clinical decision support solution for physicians. ClinicalKey’s Ask AI gives clinicians a direct, conversational way to ask clinical questions and receive concise answers drawn from more than 900 full text scientific journals, as well as thousands of clinical overviews and guidelines, books and other trusted, evidence-based content sources.
Omry Bigger, President, Clinical Solutions, Elsevier said: “This AI functionality is designed to meet clinicians at the point of care, where they need fast, reliable answers. By grounding every response exclusively in ClinicalKey’s trusted content, we’re able to combine the speed and ease of conversational AI with the clinical reliability and security our customers depend on.”
What ClinicalKey Ask AI Provides:
ClinicalKey does not pull information from the open web; it also does not store, process, or retain patient-identifiable information.
Availability
Elsevier is rolling out the Ask AI functionality to existing ClinicalKey customers in the US starting in September.
For a more personalized clinical workspace experience, Elsevier offers ClinicalKey AI. The generative AI solution, which was launched in 2024, offers:
To learn more about these solutions, please visit ClinicalKey | Elsevier
About Elsevier
Elsevier is a global leader in advanced information and decision support. For over a century, we have been helping advance science and healthcare to advance human progress. We support academic and corporate research communities, doctors, nurses, future healthcare professionals and educators across 170 countries in their vital work.
We help impact makers achieve better outcomes with research and clinical-grade solutions built on the world’s leading scientific and medical knowledge base of evidence-based content, precision AI, and expert human assessment to ensure accountability at every step.
We champion inclusion and sustainability, working with the communities that we serve. The Elsevier Foundation supports research and health partnerships around the world.
Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. For more information, visit www.elsevier.com and follow us on social media at @elsevierconnect.
SOURCE Elsevier Limited
MIMRYLO™ is the First and Only Hepcidin Mimetic Peptide Therapy Approved for the Treatment of…
Q4 Fiscal 2025 HighlightsRevenue of $2.3 million, a 29.0% increase over Q3 2025Gross profit of…
American Academy of Neurology launches new public websiteMINNEAPOLIS, Aug. 28, 2026 /PRNewswire/ -- The American Academy…
SHANGHAI, Aug. 28, 2026 /PRNewswire/ -- Sanyou Biopharmaceuticals Co., Ltd. (hereinafter referred to as "Sanyou…
Teguar's purpose-built medical and industrial systems add compatible hardware options for IGEL deployments in specialized…
Founded by Dr. Adam Z. Kawalek, SportSlip brings sports physicals online, built on the joint…